The largest database of trusted experimental protocols

8 protocols using cd45ra apc

1

CAR T Cell Immunophenotyping and Transduction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunophenotyping of the apheresis was conducted with the following fluorophore-conjugated antibodies: CD3-phycoerythrin (PE) (Beckman Coulter), CD8-PE-Cy7 (Invitrogen), CD14-allophycocyanin (APC) (eBioscience), and CD45-fluorescein isothiocyanate (FITC) (Beckman Coulter). In-process transduction efficiency of the CD19-targeted CAR T cells was evaluated with the CD3-APC (Invitrogen) and biotinylated goat-anti-mouse Fab (Jackson Immunoresearch Lab) followed by PE-conjugated streptavidin (MP Biomedicals). In-process transduction efficiency of the BCMA-targeted CAR T cells was evaluated with the CD3-APC (Invitrogen) and BCMA-Fc-APC.12 (link) The effector memory and central memory immunophenotyping was conducted using the following monoclonal antibodies: CD27-APC, CD28-FITC, CD62L-FITC, CCR7-FITC, CD45RA-APC (Invitrogen), and CD127-eFlour450 (eBioscience). Dead cells were excluded from analysis using either 7AAD or DAPI staining. Flow data acquisition was performed on an LSRII (BD Biosciences), and data analysis was performed using FlowJo Software (Tree Star).
+ Open protocol
+ Expand
2

Multiparameter Immunophenotyping of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole blood was stained with 3 panels of antibodies incubated for 20 min followed by fixation and RBC lysis using FACS lysis buffer (BD) in accordance with prescribed. Panel I consisted of integrin α4-PE (Invitrogen), integrin β7-FITC (Biolegend) CD19-PECy7 (BD Pharmingen), CD14APC (eBiosciences). Panel II consisted of integrin α4-PE (eBiosciences), integrin β7-FITC (Biolegend), CD3-PECy7 (BD Pharmingen), CD56APC (BD Pharmingen). Cells stained with both these four color panels were acquired on BD accuri C6 and analyzed using BD accuri C6 software (BD Biosciences). Panel III consisted of 5 antibodies viz. integrin β7-FITC (Biolegend), CCR7-PE (eBiosciences), CD45RA APC (Invitrogen), CD3-PECy7, CD4-PECF594 (BD Horizon). Cells stained with Panel III were acquired on FACS Aria fusion and analyzed using FlowJo VX (TreeStar, Ashland, OR,USA). Cells from the two cytobrushes were pooled and filtered through a 100-mm filter followed by staining with integrin α4-PE, integrin β7-FITC (Biolegend) and CD3-APC (BD). Viability dye 7AAD (eBiosciences) was added before acquiring the cells on BD accuri C6 flow cytometer.
+ Open protocol
+ Expand
3

Multiparametric Flow Cytometry Analysis of PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were thawed, stained with 5 μl of the HLA-A*02:01 dextramer conjugated to PE for 10 minutes at room temperature, followed by the addition of 100 μl of a mastermix of anti-membrane marker mAbs containing LIVE/DEAD fixable aqua stain (Molecular Probes, Invitrogen), CD3 ECD (Beckman Coulter), CD4 BV605 and CCR7 Pacific blue (Biolegend), CD8 Alexa Fluor 700, CD14 PE-Cy7, CD16 PE-Cy7, CD19 PE-Cy7, CD45RA APC, CD57 FITC, TIGIT PerCP-eFluor710, PD-1 APC-eFluor780 (eBiosciences) and CD27 Qdot 655 (Life Technologies). The cells were incubated at 4°C for a further 20 minutes, washed and fixed with 1% paraformaldehyde in PBS prior to running on an LSRII flow cytometer (Becton-Dickinson).
+ Open protocol
+ Expand
4

Comprehensive Immune Phenotyping of PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were thawed, incubated with 5 μl of the HLA-A*02:01/YQYMDDLV tetramer (NIH Tetramer Core Facility) conjugated to PE for 10 min at room temperature, followed by the addition of 100 μl of a mastermix of anti-membrane marker mAbs containing LIVE/DEAD fixable aqua stain (Molecular Probes, Invitrogen), CD3 ECD (Beckman Coulter), CD4 BV605 and CCR7 Pacific blue (Biolegend), CD8 Alexa Fluor 700, CD14 PE-Cy7, CD16 PE-Cy7, CD19 PE-Cy7, CD45RA APC, CD57 FITC, TIGIT PerCP-eFluor710, PD-1 APC-eFluor780 (eBiosciences) and CD27 Qdot 655 (Life Technologies). The cells were incubated at 4°C for a further 20 min, washed and fixed with 1% paraformaldehyde in PBS prior to running on an LSRII flow cytometer (Becton-Dickinson).
+ Open protocol
+ Expand
5

Isolation and Characterization of CD8+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were collected at the Blood Centers of the Pacific in San Francisco, CA. All donors were kept anonymous and provided written informed consent. Total human CD8+ T cells were enriched via negative selection using the RosetteSep human CD8+ T cell enrichment cocktail (15063; Stemcell). The following antibodies were used to stain peripheral blood mononuclear cells or enriched CD8+ naive, CD8+CD28+ memory, and CD8+CD28 T cells: CD3-PECy5 (555334; BD Biosciences) and CD3-APC-H7 (560176; BD Biosciences), CD8-V450 (560347; BD Biosciences), CD28-PE (12–0289; eBioscience), CD45RA-APC (17–0458; eBioscience), and CCR7-PECy7 (557648; BD Biosciences). Flow cytometry was performed on an LSRII or Calibur DxP8 flow cytometer (both BD Biosciences) and was analyzed with FlowJo software. Sorting was performed on an ARIA II (BD Biosciences).
+ Open protocol
+ Expand
6

Comprehensive Immune Cell Phenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies used for flow cytometry analysis included: CD2-Tri-Color (TC); CD4-Phycoerythrin (PE) and CD4Allophycocyanin (APC); CD28-Fluorescein Isothiocyanate (FITC); CD8-TC; CD19-APC; CD45RA-APC; CD16-FITC from Life Technologies (Grand Island, NY); CD14-PE; CD27-PE; and IgM-FITC from BD Biosciences (San Jose, CA). Freshly thawed PBMCs from each visit were stained with three to five antibodies: T cells (CD2, CD4, CD8, CD45RA, and CD28); B cells (CD19, IgM, and CD27); NK cells (CD16). The data were collected on a BD FACSCalibur or BD FACSCanto II, and analyzed by Cell-Quest (BD Biosciences) and FlowJo. The gating strategies were presented in Additional file 1: Figure S1.
+ Open protocol
+ Expand
7

Flow Cytometry Analysis of PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies used for flow cytometry analysis included: CD2–Tri-Colour (TC); CD4–phycoerythrin (PE) and CD4–allophycocyanin (APC); CD28–FITC; CD8–TC; CD19–APC; CD45RA–APC from Life Technologies; CD14–PE; CD27–PE and IgM–FITC from BD Biosciences. Freshly thawed PBMCs of each visit were stained with 3–4 antibodies: T-cells (CD2, CD4, CD8, CD45RA and CD28); B-cells (CD19, IgM and CD27); monocytes (CD14). The data were collected on a BD FAC-SCalibur or BD FACSCanto II and analysed by Cell-Quest (BD Biosciences).
+ Open protocol
+ Expand
8

Lentiviral Production and Immune Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK 293-FT (Life Technologies), a packaging cell line used to produce high-titer lentivirus supernatants, were cultured in complete Dulbecco’s Modified Eagle Medium (DMEM, Gibco, USA) supplemented with 10% fetal bovine serum(FBS, Gibco, USA) containing 0.1 mM MEM Non-Essential Amino Acids, 1 mM sodium pyruvate and 2 mM Glutamax (Life Technologies, USA) at 37 °C with 5% CO2.
Flow cytometry staining antibodies were shown as below: CD3-BUV395(Clone: UCHT1), CD4-PE-CF594(Clone: RPA-T4), CD8-PE-Cy7(Clone: RPA-T8), PD-1-BUV737(Clone: EH12.1), CCR7-PE(Clone: 150503), CD45RA-APC(Clone: HI100), CD137-APC(Clone: 4B4–1), CD107A-AF647(Clone: H4A3), CD107b-AF647(Clone: H4B3), Fixable Viability Stain 780 (FVS780). All antibodies were from BD Biosciences, except for anti-mouse TCR-β constant region (clone H5–597, eBioscience, USA). The blocking antibody against HLA class I were from eBioscience (clone: W6/32).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!